UACA 抗体
Quick Overview for UACA 抗体 (ABIN6940368)
抗原
See all UACA 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
纯化方法
- Purified by Protein A/G
-
免疫原
- Nuclei of myeloid leukemia biopsy cells
-
亚型
- IgG1 kappa
-
-
anti-Uveal Autoantigen With Coiled Coil Domains And Ankyrin Repeats (UACA) (AA 29-209) antibody
UACA 适用: 人 WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated
anti-Uveal Autoantigen With Coiled Coil Domains And Ankyrin Repeats (UACA) (AA 1-90) antibodyUACA 适用: 人 WB, IHC, ELISA 宿主: 兔 Polyclonal unconjugated
anti-Uveal Autoantigen With Coiled Coil Domains And Ankyrin Repeats (UACA) antibodyUACA 适用: 人, 小鼠 IHC, ELISA 宿主: 兔 Polyclonal unconjugated
anti-Uveal Autoantigen With Coiled Coil Domains And Ankyrin Repeats (UACA) (AA 1-1416) antibodyUACA 适用: 人 WB 宿主: 小鼠 Polyclonal unconjugated
anti-Uveal Autoantigen With Coiled Coil Domains And Ankyrin Repeats (UACA) (AA 1309-1358) antibodyUACA 适用: 人, 小鼠, Cow, 犬, 豚鼠, 马, 猴, Pig WB 宿主: 兔 Polyclonal unconjugated
-
-
应用备注
-
Positive Control: HeLa or 293T cells. Highly expressed in skeletal muscle, heart, kidney and pancreas. Also expressed in epidermal melanocytes, eye muscles and thyroid follicular cells.
Known Application: Flow Cytometry (0.5-1 μg/million cells), Immunofluorescence (0.5-1.0 μg/mL), Western Blot (0.5-1 μg/mL),Optimal dilution for a specific application should be determined.
-
限制
- 仅限研究用
-
-
-
浓度
- 200 μg/mL
-
缓冲液
- 10 mM PBS with 0.05 % BSA & 0.05 % azide.
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- 4 °C,-80 °C
-
储存方法
- Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.
-
有效期
- 24 months
-
-
- UACA (Uveal Autoantigen With Coiled Coil Domains And Ankyrin Repeats (UACA))
-
别名
- UACA
-
背景
- UACA (Uveal Autoantigen with Coiled-coil domains and Ankyrin repeats) is a 1,416 amino acid nuclear membrane protein. It was originally identified as an autoantigen in patients with panuveitis, a characteristic of Vogt-Koyanagi-Harada disease, and in patients with Graves' disease. UACA was also later identified as Nucling, an mRNA differentially expressed in F9 embryonal carcinoma cells during cardiac muscle differentiation. UACA appears to function as a pro-apoptotic protein that recruits the apaf-1-pro-caspase-9 complex for the induction of apoptosis to mediate the cell-death pathway.
-
分子量
- 160kDa
-
基因ID
- 55075
-
途径
- Positive Regulation of Endopeptidase Activity
抗原
-
